
Two NASA employees cited for their civic service, 'spirit of exploration'
June 17 (UPI) -- Two NASA employees are being cited for their civic work in the nation's space industry.
The Samuel J. Heyman Service to America Medals, also known as the Sammies, recognize outstanding federal employees addressing many of the country's greatest challenges.
Rich Burns from NASA's Goddard Space Flight Center in Greenbelt, Md., and John Blevins of Marshall Space Flight Center in Huntsville, Ala., were chosen out of 350 nominees and are a part of the 23 individuals and teams to earn this achievement.
"Rich and John exemplify the spirit of exploration and service that defines NASA and our nation's civil servants," said acting NASA Administrator Janet Petro. "Their leadership, ingenuity and dedication have not only advanced America's space program but also inspired the next generation of innovators. We are proud to see their achievements recognized among the very best of federal service."
Burns worked as a project manager of Origins, Spectral Interpretation, Resource Identification, and Security - Regolith Explorer (OSIRIS-REx). This mission started on Sept. 18, 2016, with a goal of retreiving a sample of an asteroid.
"It's humbling to accept an award based on the achievements of the amazingly talented, dedicated, and innovative OSIRIS-REx team," Burns said. "I consider myself privileged to be counted among a team of true explorers who let no obstacle stand in the way of discovery."
Blevins was the chief engineer of the Space Launch System (SLS) rocket. He led the team as part of Artemis l, first test flight on Nov. 16, 2022. He's currently leading the engineering team of Artemis II as that project prepares for the first crewed lunar mission.
"This is a reflection on the hard work and dedication of the entire Artemis Team," Blevins said. "I am working with an incredibly competent, dedicated team agency-wide that goes above and beyond to promote the space exploration goals of our nation. I am honored to accept the award on their behalf."
A ceremony will be held in Washington, D.C., on Tuesday and a live-stream on the Sammies website.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Miami Herald
25 minutes ago
- Miami Herald
Eli Lilly Co. to buy gene-editing startup Verve to develop cardiac drugs
June 17 (UPI) --Eli Lilly and Company said Tuesday it will buy out Boston-based Verve Therapeutics Inc. in a billion dollar deal with plans to advance Verve's new line of experimental cardiac health drugs. Indianapolis-based Eli Lilly announced its definitive agreement to acquire Verge, a gene-editing startup, for up to $1.3 billion at $10.50 a share -- a premium of 67.5% at last closing -- with the goal to boost Verve's budding pipeline of medicine designed to target and treat a wide-range of cardiovascular-related health issues. "Lilly is eager to welcome our Verve colleagues to Lilly and continue the development of these promising potential new medicines aimed at improving outcomes for patients with cardiovascular disease and addressing the significant unmet medical need in this space," said Ruth Gimeno, Lilly's group VP for diabetes and metabolic research and development. Under the agreement terms, the transaction will not be subject to any financing conditions and will include a nearly $1 billion upfront payout plus a further $300 million based on certain clinical milestones. The deal is expected to close by this year's third quarter subject to conditions. Verve's medical treatment program, according to a Gimeno, could "shift the treatment paradigm for cardiovascular disease from chronic care to one-and-done treatment." Meanwhile, stock shares in Verve jumped 76% to over $11 in premarket trading Tuesday morning while Lilly stock value fell 1%. A years-long study from 2010-2022 released in November revealed how the number of dead via cardiovascular disease had surged among adults ages 25 to 64 living in rural areas. Verve uses a next gen type of gene editing which erases and rewrites a specific gene letter. Lilly's Gimeno says the Verve-102 program, which is currently in its Phase 1b clinal trial study and fast-tracked for FDA approval, "has the potential" to be the first "in vivo" gene editing therapy deployed to treat a broad population of patients seeking treatment for cardiac issues. 102 may be utilized for patients seeking treatment for heterozygous familial hypercholesterolemia (HeFH), which is a subset of ASCVD affecting 1 in 250 people. On Tuesday, Verve's chief noted how in just seven years that the Verve team had progressed three in vivo gene editing products with two currently in clinics. "Verve was founded with one mission in mind: transform the treatment of cardiovascular disease from chronic care to a one-dose future," said Verve Therapeutics co-founder and CEO Dr. Sekar Kathiresan. Copyright 2025 UPI News Corporation. All Rights Reserved.


Bloomberg
2 hours ago
- Bloomberg
New NASA Boss May Not Take Over Till Next Year, Acting Head Says
NASA might be without a new administrator until early 2026, according to the acting head of the agency, casting doubts on the direction of the US space program after President Donald Trump last month pulled the nomination of Elon Musk's ally, Jared Isaacman. The earliest a new nominee could start the job might be in October but the process could last into March, Janet Petro, NASA's acting administrator, said on Tuesday in an interview.

Miami Herald
2 hours ago
- Miami Herald
HBCU makes history with NASA
Virginia State University is proud to announce that its College of Engineering and Technology made history at the 2025 NASA Lunabotics Challenge. The VSU Lunabotics Team was the only Historically Black College or University (HBCU) represented in this year's prestigious competition. The event took place from May 20 to May 22 at NASA's Kennedy Space Center in Florida. It brought together top student teams from across the country to compete in an intensive robotics challenge. A Nationally Recognized Robotics Competition The NASA Lunabotics Challenge is a two-semester systems engineering competition. It invites students to design, build, and operate autonomous robots capable of performing tasks on simulated lunar terrain. Students gain real-world experience in space exploration, robotics, and problem-solving. The program is designed to prepare future engineers for the demands of working in high-tech industries. Dr. Nasser Ghariban, Chair of the Department of Engineering and faculty advisor to the team, said: 'The team's perseverance and collaborative spirit throughout this challenging competition reflect their readiness for real-world engineering challenges. Participating in this competitive NASA event provided invaluable hands-on experience that will significantly benefit their future careers in technology and exploration.' A Team of Innovators and Leaders The VSU Lunabotics Team included 15 students from various academic programs. These included Computer Engineering, Computer Science, Manufacturing Engineering, and Mechanical Engineering Technology. Together, they designed and built a versatile robot that completed all required tasks during the competition. Dr. Dawit Haile, Dean of the College of Engineering and Technology, praised the team's performance: 'The strong finish by our Lunabotics team emphasizes their remarkable dedication, innovative thinking, and technical prowess. Their success as the only HBCU team in the competition underscores VSU's commitment to excellence in STEM education.' A Moment of Pride for Virginia State University This milestone showcases the university's dedication to creating opportunities in science, technology, engineering, and mathematics. The team's achievement is a source of pride not just for Virginia State University but for all HBCUs nationwide. VSU applauds the students for their hard work, creativity, and determination. Their success highlights the university's mission to provide transformational learning experiences and prepare students for success in competitive fields. The post HBCU makes history with NASA appeared first on HBCU Gameday. Copyright HBCU Gameday 2012-2025